Novartis drops pursuit of Cytokinetics - source

Swiss drugmaker Novartis (NOVN.S) has backed away from its pursuit of Cytokinetics (CYTK.O), a person familiar with the matter told Reuters, and the U.S. drug developer's shares were down over 21% in afternoon trade.